“In value investing, patience is a prerequisite to reap gains. That is why it is important for investors to stay put with their investments whether through SIP or otherwise. As value gets unlocked investors will be beneficiaries of exponential gains from these investments,” said Mrinal Singh, Deputy CIO- Equity, ICICI Prudential Mutual Fund, in an interview to Avneet Kaur of ETMutualFunds.com.ICICI Prudential Value Discovery Fund is underperforming its benchmark in one-, three- and five-year horizons. The scheme has given -8.60 per cent in the last one year, 3.31 per cent in the three-year period and 6.27 per cent in five years. What is the reason behind the underperformance?The recent performance of ICICI Prudential Value Discovery Fund has been a function of the markets being expensive w
[unable to retrieve full-text content]Earlier this year Netflix NASDAQ NFLX raised the price of its streaming service for U S subscribers for the first time since October 2017 The cost of the standard monthly pricing plan its most popular tier grew from 10 99 to 12 99 an increase of about 18 Latest Articles in
Short-haul, visaon-arrival destinations are gaining traction this summer as airfares and holiday packages to the US and Europe stay expensive due to the Jet Airways crisis and closure of Pakistani airspace. Travel to destinations like Thailand, Malaysia, Mauritius, Cambodia and the Maldives is picking up with the airlines of some of these countries also enticing travellers with attractive offers, online travel agencies and tour operators said. “Summer travel has been impacted over the past few months because of issues ranging from capacity constraint due to the grounding of Jet Airways to the closure of airspace over Pakistan that has led to an increase in airfares. We have noticed travellers favouring short-haul destinations, especially those that offer visa-free entry or visa-on-arrival
Swiss pharmaceutical giant Novartis has won approval for a new gene therapy drug which is priced at a record £1.67m per treatment.Named Zolgensma, the drug has been approved by US regulators for treating babies with spinal muscular atrophy (SMA) - a rare and often fatal disease. The new one-time treatment uses a virus to replace the defective gene which causes SMA with a copy that functions properly.The regulatory approval allows Zolgensma to be used on babies with the deadliest form of the disease as well as ones whose lives could be impacted later.Babies affected by the most severe form of the progressive condition rarely survive beyond two years of age. Advertisement "This is potentially a new standard o
If you signed up to stream live TV in hopes of saving money over traditional cable, you may be in for a rude surprise. Live online-TV providers like YouTube TV, DirecTV Now and Hulu with Live TV lured users with digital "skinny bundles" that were cheaper than cable. Now, many are raising prices. The latest is Google's YouTube TV, which is increasing its monthly fee to $ 50. It launched at $ 35 and has raised prices as it added more channels. The first of this crop of TV services was Dish Networks' Sling TV in 2015. Its most attractive feature was price, since it offered a handful of popular, live TV channels for $ 20 a month. A string of other companies announced similar services in the years that followed, many priced from $ 30-$ 40 a month. YouTube TV, Hulu Live, AT&T's...